William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Instructure Announces Launch of Initial Public Offering
-
Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021
-
Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021
-
UPDATE: William Blair Starts Kinnate Biopharma (KNTE) at Outperform
-
Ryan Specialty Announces Launch of Initial Public Offering
-
Prospect Capital Announces Pricing of $150 Million in Aggregate Liquidation Preference of 5.35% Series A Perpetual Preferred Stock
-
Prospect Capital Announces Pricing of $150 Million in Aggregate Liquidation Preference of 5.35% Series A Perpetual Preferred Stock
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2021
-
EmpiRx Health Announces Strategic Growth Investment from Nautic Partners
-
Recruiter.com Group (RCRT) Acquires Uncubed's Technology Solutions Business
-
Recruiter.com Acquires Uncubed's Technology Solutions Business
-
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
-
Allogene Therapeutics Announces Participation in Two Upcoming Virtual Investor Conferences
-
Neurana Pharmaceuticals to Participate at William Blair Biotech Conference
-
Aptinyx to Participate in William Blair Biotech Focus Conference 2021
-
Thoma Bravo Completes Strategic Growth Investment in Greenphire
-
ViaSat (VSAT) Likely to Benefit From President Biden's Executive Order to DOT
-
Lyra Therapeutics to Present at Upcoming Virtual Healthcare Conference
-
Lyra Therapeutics to Present at Upcoming Virtual Healthcare Conference
-
Atea Pharmaceuticals to Present at William Blair Biotech Focus Conference
-
Charlesbank To Make A Strategic Investment In Clearlake And SkyKnight-Backed symplr
-
UPDATE: William Blair Starts Verve Therapeutics (VERV) at Outperform
-
MaxCyte, Inc (MXCT) Files up to $100M IPO
-
MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing
-
8 Hot Penny Stocks on Robinhood That You Need to Know About
-
Form D/A William Blair Macro Allo
-
BioMedNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation in William Blair Biotech Focus Conference
-
Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
-
Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
-
VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
-
VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
-
F-star Therapeutics to Present at Upcoming Investor Conferences
-
F-star Therapeutics to Present at Upcoming Investor Conferences
-
Tempest to Participate in William Blair 2021 Biotech Focus Conference
-
Tempest to Participate in William Blair 2021 Biotech Focus Conference
-
UPDATE: William Blair Starts Latch, Inc. (LTCH) at Outperform
-
Ramaco Resources, Inc. Announces Upsizing and Pricing of Senior Unsecured Notes Offering
-
Apexigen to Participate in Upcoming Investor Conferences
-
Atlanticus Holdings Corporation Announces Closing of Over-Allotment Option in Connection with Offering of Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Holdings Corporation Announces Closing of Over-Allotment Option in Connection with Offering of Series B Cumulative Perpetual Preferred Stock
-
Celcuity to Participate in the William Blair Biotech Focus Conference
-
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021

